| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/29/2006 | CN1752212A Process for preparing PGRP (31-98) fragment by gene recombining technique |
| 03/29/2006 | CN1752103A Bone pattern generation protein 2 active peptide and its preparation method and application |
| 03/29/2006 | CN1752101A Protein separated from jellyfish and possessing antioxygenation activity and its application |
| 03/29/2006 | CN1752100A Marine organism anticancer protein and its extraction method |
| 03/29/2006 | CN1752098A Protein isolation agent |
| 03/29/2006 | CN1751743A Method for preparing 131I marker GM-CSF protein for treating leukemia |
| 03/29/2006 | CN1247260C Analogs of parathyroid hormone |
| 03/28/2006 | US7019129 at least three radicals selected from substituted or unsubstituted aryl, heteroaryl and combinations, wherein at least two of the residues are covalently linked via an exocyclic diazo bond, and a reactive functional group providing a locus for conjugation of the quencher to a carrier |
| 03/28/2006 | US7019120 Cloud-point extraction of enzymes and polypeptides from a fermentation broth using a non-ionic surfactant |
| 03/28/2006 | US7019114 Recombinant, biologically active human zona pellucida protein 3 (HZP3) to test male fertility |
| 03/28/2006 | US7019113 Reversible modification of membrane interaction |
| 03/28/2006 | US7018846 Display of receptors and analysis of binding interactions and drug libraries |
| 03/28/2006 | US7018836 P-TEFb compositions, methods and screening assays |
| 03/28/2006 | US7018814 Process of purifying vancomycin hydrochloride |
| 03/28/2006 | US7018637 Vaccines; immunology carrier containing epitope binding tocarbohydrates |
| 03/28/2006 | US7018538 the sorbent comprises a support, which is at least partially covered by a polymeric film based on primary aromatic amines especially polyanilines or derivatives of polyanilines |
| 03/28/2006 | CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/23/2006 | WO2006030119A1 Novel enzymatic substrates derived from phenoxazinone and their use as developer in detection of micro-organism with peptidase activity |
| 03/23/2006 | WO2006029775A1 Method for removing fibronectin from plasma fractions |
| 03/23/2006 | WO2005116643A3 Identification of compounds modifying a cellular response |
| 03/23/2006 | WO2005099774A3 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 03/23/2006 | WO2004016642A3 ISOFORM SPECIFIC INTERACTIONS OF APOLIPOPROTEIN E TO AN INTERMEDIATE CONFORMATION OF ALZHEIMER Aβ PEPTIDE |
| 03/23/2006 | WO2003083085A3 Transporters and ion channels |
| 03/23/2006 | US20060063918 Process for rapid solution synthesis of peptides |
| 03/23/2006 | US20060063914 Peptides having protected amines of untargeted sites, methods for production thereof and of specifically conjugated peg peptides using the same |
| 03/23/2006 | US20060063715 Multivalent antigen-binding proteins |
| 03/23/2006 | US20060063706 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals; treating infection caused by methicillin-resistant Staphylococcus aureus |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060063206 Prepared by a one-step, three-component reaction of a glyoxamide, an amine, and an organoboron derivative; also solid phase synthesis; forming peptides for a combinatorial library |
| 03/23/2006 | DE4007605B4 SDK-Peptide, Verfahren zu ihrer Herstellung und diese enthaltende therapeutischen Zusammensetzungen SDK peptides, process for their preparation and therapeutic compositions containing |
| 03/23/2006 | CA2580372A1 Isolation of growth and differentiating factors from colostrum |
| 03/23/2006 | CA2579848A1 Immobilized probes and methods of detecting conformationally altered prion proteins |
| 03/23/2006 | CA2577317A1 Process for concentration of antibodies and therapeutic products thereof |
| 03/23/2006 | CA2572632A1 Busulfan immunoassay |
| 03/22/2006 | EP1636360A1 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 03/22/2006 | EP1636250A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/22/2006 | EP1597278A4 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 03/22/2006 | EP1297016B1 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
| 03/22/2006 | EP1192119B1 Process for the preparation of 3,3-dimethylbutanal |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | CN1751119A Method of purifying protein and glucose dehydrogenase |
| 03/22/2006 | CN1751062A Water soluble animal muscle protein product |
| 03/22/2006 | CN1749274A Separating and purifying method for new recombinant human interferon alpha2b |
| 03/22/2006 | CN1749267A Protein separating and purifying method |
| 03/22/2006 | CN1246331C Method for purifying recombined human interferon alpha-2b by using affinity chromatography of expanded bed pigment |
| 03/22/2006 | CN1246036C Process for preparing glycopeptide phosphonate derivatives |
| 03/22/2006 | CN1245957C Method for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 03/21/2006 | US7015313 use as a diagnostic agent or a carrier protein conjugated to various anti-cancer drugs owing to its ability to specifically recognize N-glycolylneuraminic acid; antiproliferative agent; called lectin PPA (Philyra pisum agglutinin) |
| 03/21/2006 | US7015310 Oxidation reduction sensitive green fluorescent protein variants |
| 03/21/2006 | US7015309 Use to treat bacterial infections; drug screening for new antibiotics; 1-aminocyclohexane carboxylic acid (Chex)-Pyrrhocoricin-beta-acetyl-2,3-diaminopropionic amide |
| 03/21/2006 | US7015308 human Desert hedgehog protein of given sequence; a drug target: efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses |
| 03/21/2006 | US7015307 Process for purifying glycopeptide phosphonate derivatives |
| 03/21/2006 | US7015196 neurokinin receptor inhibitors comprising cyclic petides used for prophylaxis of respiratory system and urogenital disorders, as antitussive agents and muscle relaxants |
| 03/21/2006 | US7015047 Microdevices having a preferential axis of magnetization and uses thereof |
| 03/21/2006 | US7015041 Automated method for setting up multiple crystallization experiments in submicroliter volumes |
| 03/21/2006 | US7014869 Rapid dehydration of proteins |
| 03/21/2006 | US7014706 Crystal forming apparatus and method for using same |
| 03/21/2006 | CA2236206C Heparin chromatography of erythropoietins |
| 03/21/2006 | CA2191406C Process for removing aromatic compounds from product-containing solutions |
| 03/21/2006 | CA1341502C Method for the production of erythropoietin |
| 03/16/2006 | WO2005117538A9 METHODS AND COMPOSITIONS FOR INHIBITING ABAD/Aβ PROTEIN INTERACTION |
| 03/16/2006 | WO2005100394A3 PURIFIED INTERLEUKIN-15/Fc FUSION PROTEIN AND PREPARATION THEREOF |
| 03/16/2006 | WO2005070468A3 Transglutaminase mediated conjugation of peptides |
| 03/16/2006 | WO2004099231A3 Glycopegylation methods and proteins/peptides produced by the methods |
| 03/16/2006 | US20060058509 Refolding of membrane proteins |
| 03/16/2006 | US20060058508 Novel functional peptide nucleic acid and process for producing the same |
| 03/16/2006 | US20060058506 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 03/16/2006 | US20060058228 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system |
| 03/16/2006 | US20060058218 Solid phase conjugation of complexing agents and targeting moieties |
| 03/16/2006 | US20060057700 Using glycosylated pilin as diagnostic indicator and preventative initation in treating pseudomonal infections; immunotherapy; glycosylated with the O-antigen; Pseudomonas aeruginosa; Escherichia coli |
| 03/16/2006 | US20060057644 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 03/16/2006 | US20060054504 Two-dimensional microfluidics for protein separations and gene analysis |
| 03/16/2006 | US20060054503 Methods for manipulating droplets by electrowetting-based techniques |
| 03/16/2006 | US20060054502 Localized Chemical Microgradients |
| 03/16/2006 | DE102004038134A1 New multivalent chelator compounds containing a carbohydrate scaffold structure linked to chelator groups and coupling groups useful for modification and/or immobilization of target molecules e.g. proteins that carry an affinity-tag |
| 03/16/2006 | DE102004036017A1 Growth factors are phosphorylated using amino acids and added phosphate donors for increased effectiveness over a longer time span |
| 03/16/2006 | CA2579170A1 Crystal structure of house dust mite allergen der p 1 |
| 03/15/2006 | EP1635174A1 Method of separating sugar from compound having glycoside bond, sugar separation system, sugar separation agent kit, standardized sample for sugar separation and assessment system |
| 03/15/2006 | EP1634889A2 Free solution ligand interaction molecular separation method |
| 03/15/2006 | EP1634076A2 Binding peptides: methods for their generation and use |
| 03/15/2006 | EP1633851A2 Methods and compositions for amino acid production |
| 03/15/2006 | EP1633773A2 D-amino acid peptides |
| 03/15/2006 | EP1633772A2 Aav virions with decreased immunoreactivity and uses therefor |
| 03/15/2006 | EP1633189A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 03/15/2006 | EP1196429B1 Process for the deprotection of protected thiols |
| 03/15/2006 | EP0794960B2 An aglucone isoflavone enriched vegetable protein concentrate and process for producing |
| 03/15/2006 | CN1747965A Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 03/15/2006 | CN1747712A Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 03/15/2006 | CN1245246C Method and apparatus for continuous flow isoelectric focusing for purifying biological substances |
| 03/15/2006 | CN1245216C Stabilized liquid polypeptide-containing. pharmaceutical compositions |
| 03/14/2006 | US7012132 Modified factor VIII |
| 03/14/2006 | US7012131 Pro1410 polypeptides |
| 03/14/2006 | US7012130 differential saline precipitation, hydrophobic interaction chromatography, concentration and diafiltration, anionic exchange chromatography, cationic exchange chromatography, concentration and diafiltration, and molecular exclusion chromatography |
| 03/14/2006 | CA2389816C Method for characterising and separating molecular associates |
| 03/14/2006 | CA2324348C Methods and compositions for peptide synthesis |
| 03/14/2006 | CA2257294C Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| 03/14/2006 | CA2171317C Method for purifying egg yolk immunoglobulins |
| 03/14/2006 | CA1341501C Vectors for the expression and segregation of hirudine by transformed yeasts |
| 03/09/2006 | WO2006026416A1 Compositions, methods, systems, and kits for affinity purification |
| 03/09/2006 | WO2006025425A1 Protein participating in inhibition of plasmodium growth |